Tag Archives: Albireo Pharma Inc

Albireo Pharma Inc Has a New Rating from Needham

Needham analyst Alan Carr initiated coverage with a Buy rating on Albireo Pharma Inc (NASDAQ: ALBO) today and set a price target of $50. The company’s shares opened today at $35. Carr observed: “Albireo mgmt hosted a 4Q17 conference call

Analysts Offer Insights on Healthcare Companies: Albireo Pharma Inc (NASDAQ: ALBO) and Nucana Plc (NASDAQ: NCNA)

There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Albireo Pharma Inc (NASDAQ: ALBO) and Nucana Plc (NASDAQ: NCNA) with bullish sentiments. Albireo Pharma Inc (NASDAQ: ALBO) In a report released

Analysts Are Bullish on These Healthcare Stocks: ALBO, ZYNE

There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Albireo Pharma Inc (NASDAQ: ALBO) and Zynerba Pharmaceuticals (NASDAQ: ZYNE) with bullish sentiments. Albireo Pharma Inc (NASDAQ: ALBO) In a report released

Albireo Pharma Inc Receives a New Rating from a Top Analyst

Cowen & Co. analyst Ritu Baral assigned a Buy rating to Albireo Pharma Inc (NASDAQ: ALBO) yesterday. The company’s shares opened today at $25.99. Baral said: “Albireo reported 3Q earnings today and provided a brief summary of recent progress.” According

Analysts Offer Insights on Healthcare Companies: Albireo Pharma Inc (NASDAQ: ALBO) and Boston Scientific Corp (NYSE: BSX)

There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Albireo Pharma Inc (NASDAQ: ALBO) and Boston Scientific Corp (NYSE: BSX) with bullish sentiments. Albireo Pharma Inc (NASDAQ: ALBO) In a report